| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.62 | 0.02 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |